Skip to content

A randomized controlled study on the effect of pre-rehabilitation program on postoperative pulmonary complications in patients with liver cancer

A randomized controlled study on the effect of pre-rehabilitation program on postoperative pulmonary complications in patients with liver cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055426
Enrollment
Unknown
Registered
2022-01-09
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Group A:Pre-rehabilitation program was started 5-7 days before surgery, and routine perioperative management was performed after admission
Group B:Implementation of routine perioperative management plan after admission

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult patients with primary liver cancer, aged >=18 years; 2. Determine to accept liver resection; 3. Child-Pugh grading before surgery is A or B; 4. The chief surgeons of the operation all have the title of deputy chief physician or above, which can ensure the quality of the operation; 5. Normal cognitive ability, conscious and willing to participate in the research.

Exclusion criteria

Exclusion criteria: 1. Patients with infection before surgery; 2. Those who received interventional, immune biological and other treatments before surgery; 3. Metastatic liver cancer, extensive intra-abdominal metastasis of tumor, palliative surgery and radiofrequency ablation; 4. Patients undergoing emergency hepatectomy.

Design outcomes

Primary

MeasureTime frame
Pulmonary complications;

Secondary

MeasureTime frame
Hospital costs;Length of hospital stay;Readmission rate;Lung function;Self-reported symptoms;Quality of life;

Countries

China

Contacts

Public ContactWu Menghang

West China Hospital, Sichuan University

wumh1126@126.com+86 18980602145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026